Talus Bio
PrivateLast Round
Seed
Aug 20, 2024
Est. Valuation
$19.7M
Total Funding Raised
$24.26M
Company Overview
Talus Bio is a biotechnology company that offers a data-enabled drug development platform for small-molecule therapies in oncology, integrating cell processing, high-sensitivity quantitative proteomics, and machine learning analytics to enhance drug discovery through gene regulation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Talus Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Talus Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 20, 2024 | ||||
| Grant | Aug 18, 2023 | ||||
| Seed | Jun 6, 2022 | ||||
| Pre Seed | Oct 1, 2020 |
Key People
Founding team and executive leadership
Talus Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Seed |
| NIH RADx | Seed, Grant |
| WRF Capital | Seed |
| Boom Capital | Seed |
| Two Bear Capital | Seed |
| Washington Research Foundation Capital | Seed |
| BoxOne Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2025
Presented preclinical data on transcription factor therapeutic programs at AACR 2025.
- Apr 25, 2025
Presented at the AACR Annual Meeting 2025.
Talus Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Talus Bio's valuation, stock price, and market status.